Princeton Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Princeton Capital Management LLC

$313 Million
Q3 2024

A detailed history of Princeton Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Princeton Capital Management LLC holds 1,245 shares of REGN stock, worth $889,515. This represents 0.42% of its overall portfolio holdings.

Number of Shares

1,245

Previous 1,284 3.04%

Holding current value

$889,515

Previous $1.35 Million 3.04%

% of portfolio

0.42%

Previous 0.45%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1024.09 - $1201.76 $39,939 - $46,868	-39 Reduced 3.04%	1,245 $1.31 Million
Q2 2024 Aug 01, 2024	BUY	$883.2 - $1071.19 $346,214 - $419,906	392 Added 43.95%	1,284 $1.35 Million
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $31,594 - $34,767	35 Added 4.08%	892 $858,000
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $10,852 - $12,343	14 Added 1.66%	857 $752,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $59,502 - $70,579	85 Added 11.21%	843 $605,000
Q1 2023 May 01, 2023	SELL	$680.49 - $826.97 $10,887 - $13,231	-16 Reduced 2.07%	758 $622,000
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $9,183 - $11,589	16 Added 2.11%	774 $533,000
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $9,521 - $11,174	-16 Reduced 2.07%	758 $529,000
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $48,369 - $59,716	89 Added 12.99%	774 $489,000
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $6,146 - $7,261	13 Added 1.93%	685 $383,000
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $300,202 - $368,390	672 New	672 $318,000
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $72,644 - $99,775	-265 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$372.08 - $439.57 $4,092 - $4,835	-11 Reduced 3.99%	265 $109,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $66,156 - $79,398	-197 Reduced 41.65%	276 $103,000
Q3 2018 Nov 08, 2018	SELL	$351.14 - $408.51 $984,596 - $1.15 Million	-2,804 Reduced 85.57%	473 $191,000
Q2 2018 Aug 02, 2018	SELL	$284.6 - $344.99 $13,945 - $16,904	-49 Reduced 1.47%	3,277 $1.13 Million
Q1 2018 May 03, 2018	SELL	$315.82 - $393.78 $113,063 - $140,973	-358 Reduced 9.72%	3,326 $1.15 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $1.32 Million - $1.73 Million	3,684	3,684 $1.39 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Account

Princeton Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History